# PIMA_Diabetes_Prediction
MLOps with Github Actions for GABA

# Zero Shot Gemini Lite
## Feasibility Report

### 1 Product Overview
| Attribute | Proposed Product | Existing Product |
|----------|------------------|------------------|
| Product Name | Not specified (LVAD) | PaceWell Internal Pacemaker |
| Device Type | Implantable Mechanical Circulatory Support System | Class III Medical Device (FDA) |
| Intended Use | Provides hemodynamic support for patients with advanced heart failure | Provides electrical stimulation to regulate heartbeats in patients with arrhythmia |
| Regulatory Classification | Class III (FDA) | Class III Medical Device (FDA) |

### 2 Technical Specifications
| Specification | Proposed Product | Existing Product |
|--------------|------------------|------------------|
| Pump / Core Function | Axial or centrifugal flow blood pump | Pulse Generator (0.1–10V amplitude) |
| Flow / Performance Range | 2–10 L/min | 30–180 bpm |
| Power Source | Rechargeable Lithium-ion (min 6-hour runtime) | Hermetically sealed Lithium-Iodine battery |
| Weight / Size Requirement | ≤ 400 grams (implantable unit) | Not specified |
| Sterilization Requirement | EtO or Gamma | Ethylene Oxide (EtO) |

### 3 Core Electronic Components
| Component Type | Proposed Product | Existing Product |
|----------------|------------------|------------------|
| Microcontroller Unit | ARM Cortex-M4 or equivalent | MSP430FR6989 |
| Battery | Lithium-ion, 14V, 5000mAh | CFx-Li-I2 |
| Communication Module | BLE 5.0 / RF Telemetry | Bluetooth Low Energy (BLE) |
| Power Management IC | Medically certified PMIC | Not specified |
| Sensors | High-precision pressure and flow sensors | Not specified |

### 4 Mechanical Components
| Component Type | Proposed Product | Existing Product |
|----------------|------------------|------------------|
| Housing | Titanium Grade 23 | Titanium Alloy (Grade 5) |
| Moving/Internal Mechanical Part | Impeller (PEEK) | Not specified |
| Drive Mechanism | Magnetic levitation / Hydrodynamic bearings | Not specified |
| Tubing / Connectors | Medical-grade silicone | Not specified (Lead Wires: Coated MP35N Alloy) |

### 5 Control & Monitoring Unit
| Step No. | Process Description (Proposed Product) | Process Description (Existing Product) |
|----------|----------------------------------------|----------------------------------------|
| 1 | OLED touchscreen for interface | Wireless telemetry programming interface |
| 2 | Audio and visual alarm system | Automatic shutdown (protection) |
| 3 | 30-day operational data storage | Not specified |
| 4 | USB-C and Bluetooth connectivity | Wireless connectivity |
| 5 | Redundant power supply with auto-switching | Current limiter / EMI shielding |

### 6 Capabilities, Limitations, and Adjustments

#### 6.1 Capabilities we have for production
| Capability | Description | Analysis |
|------------|-------------|----------|
| Titanium Machining | CNC machining of Titanium casings | Facility is experienced with high-grade titanium housings (Grade 5), applicable to Grade 23. |
| PCB Assembly | SMT and Reflow soldering (IPC Class 3) | Existing PCB assembly equipment can handle complex medical-grade circuits. |
| Sterilization | Ethylene Oxide (EtO) | Existing sterilization workflow covers EtO, which is acceptable for the proposed LVAD. |

#### 6.2 Limitations & Constraints of existing capabilities
| Limitation | Description | Analysis |
|------------|-------------|----------|
| Mechanical Complexity | Rotating parts and drive systems | The existing pacemaker has no moving internal parts; the LVAD requires precision magnetic levitation/bearings. |
| Specialized Materials | PEEK machining | Current facility lacks specific tooling/experience for machining Polyetheretherketone (PEEK) impellers. |
| Testing Equipment | Hemodynamic validation | Existing testing (Oscilloscope/Multimeter) validates electrical signals, not hydraulic/mechanical flow/pressure. |

#### 6.3 Necessary Adjustments for Production
| Adjustment Required | Description | Analysis |
|------------|-------------|----------|
| New Equipment Acquisition | Dynamic testing/calibration systems | Must acquire flow/pressure simulation equipment to validate LVAD hemodynamic performance. |
| Material Handling | PEEK processing setup | Need to establish cleanroom tooling capable of machining PEEK impellers for blood contact. |
| Power Infrastructure | Li-ion handling | Existing production handles Lithium-Iodine; Lithium-ion (14V, 5000mAh) requires different handling/charging standards. |

#### 6.4 Conclusion & Recommendation
**Overall Feasibility:**
The manufacturing of the LVAD is partially feasible. The facility possesses the fundamental requirements for Class III medical device manufacturing, including ISO 13485 certification, biocompatible titanium machining, and sterilized packaging environments. However, the existing infrastructure is optimized for electronic pulse generation, not mechanical fluid displacement.

**Key Considerations:**
The proposed device requires significant mechanical innovations (magnetic levitation, PEEK impellers, and hydrodynamic bearing assembly) that are entirely absent in the current pacemaker production line. Additionally, the testing protocols for hemodynamic flow (pressure/flow sensing) differ substantially from electrical pulse output testing.

**Final Recommendation:**
Production is recommended only if the facility invests in specialized mechanical assembly machinery and advanced hemodynamic testing equipment. It is advised to conduct a pilot phase focusing on the assembly of the pump and drive mechanism before committing to full-scale production.

# Gemini Zero Shot High Temp
## Feasibility Report

### 1 Product Overview
| Attribute | Proposed Product | Existing Product |
|----------|------------------|------------------|
| Product Name | Not specified | PaceWell Internal Pacemaker |
| Device Type | Implantable Mechanical Circulatory Support System | Class III Medical Device (FDA) |
| Intended Use | Hemodynamic support for heart failure | Regulate heartbeats in patients with arrhythmia |
| Regulatory Classification | U.S. FDA Class III | Class III Medical Device (FDA) |

### 2 Technical Specifications
| Specification | Proposed Product | Existing Product |
|--------------|------------------|------------------|
| Pump / Core Function | Axial or centrifugal flow blood pump | Programmable pulse generator |
| Flow / Performance Range | 2–10 L/min | 30–180 bpm |
| Power Source | Rechargeable Lithium-ion (14V, 5000mAh) | Hermetically sealed lithium battery (Li-I2) |
| Weight / Size Requirement | ≤ 400 grams (implantable unit) | Not specified |
| Sterilization Requirement | EtO or gamma sterilization | Ethylene Oxide (EtO) sterilization |

### 3 Core Electronic Components
| Component Type | Proposed Product | Existing Product |
|----------------|------------------|------------------|
| Microcontroller Unit | ARM Cortex-M4 or equivalent | MSP430FR6989 |
| Battery | Lithium-ion (6-hour min runtime) | CFx-Li-I2 (Lithium-Iodine) |
| Communication Module | BLE 5.0 / RF Telemetry | Bluetooth Low Energy (BLE) |
| Power Management IC | Medically certified PMIC | Not specified |
| Sensors | High-precision pressure and flow sensors | Not specified |

### 4 Mechanical Components
| Component Type | Proposed Product | Existing Product |
|----------------|------------------|------------------|
| Housing | Titanium Grade 23 | Titanium Alloy (Grade 5) |
| Moving/Internal Mechanical Part | Impeller (PEEK) | Not specified |
| Drive Mechanism | Magnetic levitation / Hydrodynamic bearings | Not specified |
| Tubing / Connectors | Medical-grade silicone | Coated MP35N Alloy (Lead Wires) |

### 5 Control & Monitoring Unit
| Step No. | Process Description (Proposed Product) | Process Description (Existing Product) |
|----------|----------------------------------------|----------------------------------------|
| 1 | OLED touchscreen patient/clinician interface | Wireless telemetry for remote adjustments |
| 2 | Audio/visual alarms (battery, occlusion, etc.) | Automatic shutdown and Current Limiter safety |
| 3 | Minimum 30-day data storage history | Not specified |
| 4 | USB-C and Bluetooth connectivity | Non-invasive inductive charging |
| 5 | Redundant power with automatic switching | Firmware upgrades via charging interface |

### 6 Capabilities, Limitations, and Adjustments

#### 6.1 Capabilities we have for production
| Capability | Description | Analysis |
|------------|-------------|----------|
| Titanium Casing | Laser welding (Trumpf TruLaser 5000) and CNC machining | High feasibility; facility already handles biocompatible titanium housings. |
| PCB Fabrication | High-Density Interconnect (HDI) / IPC Class 3 | Current infrastructure (ASM Pick-and-Place) is compatible with medical-grade ARM Cortex components. |
| Sterilization | Ethylene Oxide (EtO) workflow | Current sterilization processes match the LVAD EtO requirements. |

#### 6.2 Limitations & Constraints of existing capabilities
| Limitation | Description | Analysis |
|------------|-------------|----------|
| Drive Mechanisms | Mechanical pump assembly | Existing documentation shows no capability for magnetic levitation or bearing assembly. |
| Specialized Testing | Hemodynamic monitoring and calibration | Testing equipment is for electrical pulses, not flow rate (2–10 L/min) or fluid pressure. |
| Component Material | PEEK processing | The facility lists alloys and silicone but lacks equipment for PEEK impeller fabrication/inspection. |

#### 6.3 Necessary Adjustments for Production
| Adjustment Required | Description | Analysis |
|--------------------|-------------|----------|
| Test Equipment Upgrade | Flow and pressure simulation | Acquisition of signal generators or benches specifically for hemodynamic activity is required. |
| Material Sourcing | Titanium Grade 23 and PEEK | Suppliers must be onboarded for Grade 23 titanium and PEEK polymers. |
| Quality Protocols | ISO 14708-5 compliance | Standard shift from ISO 14708-1 (Pacemakers) to ISO 14708-5 (Circulatory Support) required. |

#### 6.4 Conclusion & Recommendation
**Overall Feasibility:** Moderate. 

**Key Considerations:** 
The manufacturer possesses excellent electronics, housing, and regulatory foundations for Class III devices. However, the core of the proposed product—a mechanical pump with magnetic levitation—is fundamentally different from the static electronic pulse generators currently produced. Current testing equipment (Oscilloscopes and Multimeters) cannot validate the 2–10 L/min flow requirements.

**Final Recommendation:** 
Proceed with caution. Production of the housing and PCB units is feasible with current equipment. However, it is recommended to outsource the mechanical drive (mag-lev impeller) assembly and invest in a specialized hemodynamic calibration laboratory to meet the proposed monitoring and flow specifications.

# Gemini CoT Hight Temp
## Feasibility Report

### 1 Product Overview
| Attribute | Proposed Product | Existing Product |
|----------|------------------|------------------|
| Product Name | Left Ventricular Assist Device (LVAD) | PaceWell Internal Pacemaker |
| Device Type | Implantable Mechanical Circulatory Support System | Class III Medical Device (FDA) |
| Intended Use | Provides hemodynamic support for patients with advanced heart failure | Provides electrical stimulation to regulate heartbeats in patients with arrhythmia |
| Regulatory Classification | U.S. FDA Class III | Class III Medical Device (FDA) |

### 2 Technical Specifications
| Specification | Proposed Product | Existing Product |
|--------------|------------------|------------------|
| Pump / Core Function | Axial flow or centrifugal flow blood pump | Programmable output pulse generator (0.1–10V amplitude) |
| Flow / Performance Range | Adjustable, 2–10 L/min | Frequency Range: 30–180 bpm (adjustable in 1 bpm increments) |
| Power Source | Rechargeable lithium-ion battery (minimum 6-hour runtime) with backup redundant supply | Hermetically sealed lithium-iodine battery (CFx-Li-I2), 8–12 years life |
| Weight / Size Requirement | ≤ 400 grams (implantable unit) | Not specified |
| Sterilization Requirement | Must withstand EtO (Ethylene Oxide) or gamma sterilization | Ethylene Oxide (EtO) sterilization |

### 3 Core Electronic Components
| Component Type | Proposed Product | Existing Product |
|----------------|------------------|------------------|
| Microcontroller Unit | ARM Cortex-M4 or equivalent | MSP430FR6989 (Supplier: Texas Instruments, USA) |
| Battery | Rechargeable Lithium-ion, 14V, 5000mAh with fail-safe protection | CFx-Li-I2 Lithium-Iodine battery (Supplier: Greatbatch Medical, USA) |
| Communication Module | BLE 5.0 / RF Telemetry | Bluetooth Low Energy (BLE) (Supplier: Nordic Semiconductor, Norway) |
| Power Management IC | Medically certified PMIC | Not specified |
| Sensors | High-precision pressure and flow sensors | Not specified (Device lists biocompatible Platinum-Iridium Alloy electrodes by Medtronic) |

### 4 Mechanical Components
| Component Type | Proposed Product | Existing Product |
|----------------|------------------|------------------|
| Housing | Titanium Grade 23 (with hemocompatible coating to prevent thrombosis) | Titanium Alloy (Grade 5) (Supplier: Carpenter Technology, USA) |
| Moving/Internal Mechanical Part | Impeller (Polyetheretherketone - PEEK) | Not specified |
| Drive Mechanism | Magnetic levitation / Hydrodynamic bearings | Not specified |
| Tubing / Connectors | Medical-grade silicone tubing | Coated MP35N Alloy Lead Wires and Medical-Grade Silicone Rubber insulation |

### 5 Control & Monitoring Unit
| Step No. | Process Description (Proposed Product) | Process Description (Existing Product) |
|----------|----------------------------------------|----------------------------------------|
| 1 | **User Interface:** OLED touchscreen for patient and clinician interface on External Controller. | **Programming Interface:** Wireless telemetry for remote device parameter adjustments. |
| 2 | **Alarm System:** Audio and visual alerts on External Controller for low battery, occlusion, or malfunction. | **Protection / Shutdown:** Automatic protection against voltage spikes and overheating, and current limiting. |
| 3 | **Data Storage:** Minimum 30-day operational history storage capability. | **Data Diagnostics:** Not specified. |
| 4 | **External Connectivity:** USB-C and Bluetooth for telemetry and data transfer. | **Telemetry Module:** Bluetooth Low Energy (BLE) module for remote programming. |
| 5 | **System Backup:** Minimum 12-hour external battery backup in case of primary power failure. | **Charging:** Non-invasive inductive charging and firmware upgrades. |

### 6 Capabilities, Limitations, and Adjustments

#### 6.1 Capabilities we have for production
| Capability | Description | Analysis |
|------------|-------------|----------|
| Quality System Framework | Certified compliance with ISO 13485:2016, IEC 60601-1, and IEC 60601-1-2 guidelines. | Core compliance standards match. MedTech Innovations is well-equipped to execute Class III level medical production and testing. |
| PCB Fabrication & SMT Line | High-Density Interconnect (HDI) multilayer lines with SMT pick-and-place and reflow capabilities (ASM Siplace, Heller MK7). | Existing capabilities can successfully manufacture high-complexity circuit boards required for implant control systems. |
| Biocompatible Sealing & Assembly | Ultrasonic bonding (Branson 2000Xc) and laser hermetic seal processing (Trumpf TruLaser). | Established tooling for handling biomedical silicone insulation and precision laser sealing can adapt to active electronics cases. |
| Cleanroom Packaging & Sterilization | Primary Tyvek sterile pouching and subsequent EtO sterilization. | Proposed requirements for EtO sterilization line validation can directly rely on pre-existing qualified standard steps. |

#### 6.2 Limitations & Constraints of existing capabilities
| Limitation | Description | Analysis |
|------------|-------------|----------|
| No Fluid Drive Assembly Capability | Pacemakers are electronic-pulse medical devices; there is no infrastructure for processing moving fluid mechanics. | No current tools exist to fabricate or check high-tolerance mechanical moving impellers, magnetic levitations, or hydrodynamic bearings. |
| Battery Technology Gaps | Sourced lithium-iodine batteries (primary cell) compared to proposed active multi-amp rechargeable Li-ion requirements. | Equipment does not cover the heavy high-amperage rechargeable safety circuits (14V, 5000mAh) or redundant battery-switching verification tests. |
| Lack of Materials Coating/Treatments | Requirement for Hemocompatible coatings (antithrombotic) on titanium hulls. | Facility current supply line handles non-coated Grade 5 Titanium but does not utilize or control anti-clotting active blood coatings. |
| Missing Component Interfaces | Sourcing of specialized components such as medically certified PMICs, flow sensors, pressure sensors, and Grade 23 Titanium. | No active vendors in existing documentation currently provide high-accuracy pressure and flow sensors or PEEK pump housings. |

#### 6.3 Necessary Adjustments for Production
| Adjustment Required | Description | Analysis |
|--------------------|-------------|----------|
| Pump-Assembly Tooling Sourcing | Introduce bearing assembly, precision magnetic rotor alignment, and testing units. | High engineering tooling up-charge and testing cleanroom segment creation are required before manufacturing physical pumps. |
| Acoustics Integration & Chamber Tests | Add testing equipment for operational acoustic emissions monitoring (noise ≤ 25 dB constraint). | Testing systems currently verify visual and electronic signals, meaning microphone/auditory analysis structures must be built. |
| Coating Operations Setup | Partner with chemical application providers or install dynamic cleanroom spray chambers for clinical antithrombic layers. | Crucial safety aspect requiring secondary certification path to satisfy ISO 10993-1 blood contact compatibility. |
| ISO Regulatory Scopes Bridge | Transition from Pacemaker specifics (ISO 14708-1) to heart circulatory-specific guidelines (ISO 14708-5). | Internal design files and risk analysis paperwork must undergoes localized certification transitions to ensure implant clearance. |
| Dedicated Controller Production Lines | Erect unique subassembly area for clinical patient handheld units, touchscreen, alarm, and physical ports (USB-C). | Standard pacemaker line builds purely sub-dermal systems, hence external patient interactive products represent completely new layouts. |

#### 6.4 Conclusion & Recommendation

**Overall Feasibility:**  
Medium-Low. While existing operations have a strong grasp of FDA Class III regulatory pathways, sterilization compliance (EtO), IPC Class 3 multi-layer PCB creation, and biocompatible material handling (Grade 5 Titanium, Medical Silicone), the transition from low-power electronic pulsers (Pacemakers) to highly active hydrodynamic fluid circulation systems (LVADs) presents critical technology mismatches.

**Key Considerations:**  
1. *Mechanical Processing Gap:* Dynamic rotational equipment fabrication (mag-lev impellers, low-friction systems with active acoustics controls ≤ 25 dB) represents an unestablished mechanical technology branch within existing structures.
2. *Control Unit Manufacturing:* Setting up a reliable packaging and QA scheme for physical patient touchscreens (External Controllers with OLED displays, physical USB-C systems, audible alerts) has no baseline under the purely wireless subcutaneous systems of current pacing structures.
3. *Materials Validation:* Establishing Grade 23 Titanium processing alongside specialized antithrombic coating steps is highly specialized and is absent from our current platform parameters.

**Final Recommendation:**  
It is recommended to seek specialized sub-contracting support for the pump hardware core (magnetic levitation drives, PEEK impellers, and biocompatibility coating processes) rather than building these systems from scratch internally. MedTech Innovations should restrict in-house manufacturing roles initially to producing the active electronic boards (the ARM Cortex-M4 controls layout, communication lines, PMIC control architectures) and carrying out final product packaging, labels, and EtO sterile validation steps. All physical pumping mechanics must either utilize independent specialized vendor assemblies or reside within fully customized dedicated manufacturing cleanrooms built separately.
